Hologic Toekomstige groei
Future criteriumcontroles 1/6
Hologic zal naar verwachting groeien in winst en omzet met respectievelijk 9.2% en 4.9% per jaar. De winst per aandeel zal naar verwachting groeien met 10.9% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 17.6% zijn.
Belangrijke informatie
9.2%
Groei van de winst
10.9%
Groei van de winst per aandeel
| Medical Equipment winstgroei | 17.4% |
| Inkomstengroei | 4.9% |
| Toekomstig rendement op eigen vermogen | 17.6% |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 05 Nov 2024 |
Recente toekomstige groei-updates
Recent updates
When Should You Buy Hologic, Inc. (NASDAQ:HOLX)?
Nov 02
Hologic: Continued Room Amidst Bolt-On M&A Efforts
Oct 28Hologic (NASDAQ:HOLX) Seems To Use Debt Rather Sparingly
Oct 17Hologic (NASDAQ:HOLX) Has More To Do To Multiply In Value Going Forward
Sep 16Hologic, Inc. (NASDAQ:HOLX) Not Flying Under The Radar
Sep 01Hologic Has A Lot Of Fine Qualities, But A Discount Valuation Isn't Among Them
Aug 27Is There Now An Opportunity In Hologic, Inc. (NASDAQ:HOLX)?
Jul 21These 4 Measures Indicate That Hologic (NASDAQ:HOLX) Is Using Debt Reasonably Well
Jun 20Returns At Hologic (NASDAQ:HOLX) Appear To Be Weighed Down
May 22Hologic: Women's Health Play Looks Healthier Itself
May 13Getting In Cheap On Hologic, Inc. (NASDAQ:HOLX) Might Be Difficult
Apr 19Calculating The Intrinsic Value Of Hologic, Inc. (NASDAQ:HOLX)
Apr 05Hologic (NASDAQ:HOLX) Has A Pretty Healthy Balance Sheet
Mar 20Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching
Feb 22Hologic: Prospects For Growth As Headwinds Disappear
Feb 11We Think You Can Look Beyond Hologic's (NASDAQ:HOLX) Lackluster Earnings
Feb 09Hologic, Inc. Just Beat EPS By 32%: Here's What Analysts Think Will Happen Next
Feb 06We Like These Underlying Return On Capital Trends At Hologic (NASDAQ:HOLX)
Jan 29The Price Is Right For Hologic, Inc. (NASDAQ:HOLX)
Dec 30Are Investors Undervaluing Hologic, Inc. (NASDAQ:HOLX) By 25%?
Dec 11We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt
Nov 08Should You Think About Buying Hologic, Inc. (NASDAQ:HOLX) Now?
Oct 25Slowing Rates Of Return At Hologic (NASDAQ:HOLX) Leave Little Room For Excitement
Sep 28Hologic, Inc.'s (NASDAQ:HOLX) Intrinsic Value Is Potentially 35% Above Its Share Price
Aug 29We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt
Jul 31Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching
Jul 18Return Trends At Hologic (NASDAQ:HOLX) Aren't Appealing
Jun 21Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)
May 22We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt
Apr 25What Does Hologic, Inc.'s (NASDAQ:HOLX) Share Price Indicate?
Apr 10Hologic's (NASDAQ:HOLX) Returns On Capital Are Heading Higher
Mar 13Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)
Feb 14Hologic (NASDAQ:HOLX) Seems To Use Debt Quite Sensibly
Jan 18Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 9/30/2027 | 4,672 | 1,004 | 1,227 | 1,218 | 8 |
| 9/30/2026 | 4,437 | 923 | 1,155 | 1,209 | 16 |
| 9/30/2025 | 4,181 | 834 | 1,002 | 1,095 | 15 |
| 9/30/2024 | 4,020 | 803 | 1,007 | 1,070 | 18 |
| 6/29/2024 | 3,988 | 702 | 1,015 | 1,177 | N/A |
| 3/30/2024 | 3,961 | 467 | 949 | 1,104 | N/A |
| 12/30/2023 | 3,969 | 515 | 859 | 1,018 | N/A |
| 9/30/2023 | 4,030 | 456 | 901 | 1,051 | N/A |
| 7/1/2023 | 4,038 | 484 | 832 | 961 | N/A |
| 4/1/2023 | 4,057 | 753 | 841 | 959 | N/A |
| 12/31/2022 | 4,466 | 990 | 1,696 | 1,815 | N/A |
| 9/24/2022 | 4,863 | 1,302 | 1,999 | 2,126 | N/A |
| 6/25/2022 | 5,226 | 1,512 | 2,283 | 2,423 | N/A |
| 3/26/2022 | 5,392 | 1,552 | 2,598 | 2,755 | N/A |
| 12/25/2021 | 5,494 | 1,716 | 2,068 | 2,245 | N/A |
| 9/25/2021 | 5,632 | 1,872 | 2,146 | 2,330 | N/A |
| 6/26/2021 | 5,663 | 2,038 | 2,108 | 2,307 | N/A |
| 3/27/2021 | 5,317 | 1,907 | 1,677 | 1,867 | N/A |
| 12/26/2020 | 4,536 | 1,384 | 1,263 | 1,433 | N/A |
| 9/26/2020 | 3,776 | 1,115 | 740 | 897 | N/A |
| 6/27/2020 | 3,295 | 497 | 573 | 702 | N/A |
| 3/28/2020 | 3,325 | 453 | 518 | 643 | N/A |
| 12/28/2019 | 3,387 | 84 | 536 | 659 | N/A |
| 9/28/2019 | 3,367 | -204 | 536 | 650 | N/A |
| 6/29/2019 | 3,315 | -30 | 520 | 634 | N/A |
| 3/30/2019 | 3,287 | -11 | 596 | 705 | N/A |
| 12/29/2018 | 3,258 | -419 | 562 | 668 | N/A |
| 9/29/2018 | 3,218 | -111 | 627 | 733 | N/A |
| 6/30/2018 | 3,207 | -79 | 560 | 667 | N/A |
| 3/31/2018 | 3,189 | -132 | N/A | 21 | N/A |
| 12/30/2017 | 3,116 | 1,076 | N/A | 8 | N/A |
| 9/30/2017 | 3,059 | 756 | N/A | 8 | N/A |
| 7/1/2017 | 2,983 | 765 | N/A | 70 | N/A |
| 4/1/2017 | 2,894 | 790 | N/A | 729 | N/A |
| 12/31/2016 | 2,872 | 332 | N/A | 796 | N/A |
| 9/24/2016 | 2,833 | 331 | N/A | 798 | N/A |
| 6/25/2016 | 2,809 | 264 | N/A | 802 | N/A |
| 3/26/2016 | 2,785 | 208 | N/A | 797 | N/A |
| 12/26/2015 | 2,747 | 187 | N/A | 804 | N/A |
| 9/26/2015 | 2,705 | 132 | N/A | 797 | N/A |
| 6/27/2015 | 2,641 | 135 | N/A | 685 | N/A |
| 3/28/2015 | 2,580 | 116 | N/A | 601 | N/A |
| 12/27/2014 | 2,549 | 52 | N/A | 513 | N/A |
| 9/27/2014 | 2,531 | 17 | N/A | 508 | N/A |
| 6/28/2014 | 2,477 | -1,125 | N/A | 455 | N/A |
| 3/29/2014 | 2,470 | -1,147 | N/A | 543 | N/A |
| 12/28/2013 | 2,458 | -1,181 | N/A | 488 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei HOLX ( 9.2% per jaar) ligt boven de spaarquote ( 2.6% ).
Winst versus markt: De winst van HOLX ( 9.2% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 15.4% per jaar).
Hoge groeiwinsten: De winst van HOLX zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van HOLX ( 4.9% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 8.8% per jaar).
Hoge groei-inkomsten: De omzet van HOLX ( 4.9% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen HOLX zal naar verwachting over 3 jaar laag zijn ( 17.6 %).